Where does ILiAD Biotechnologies's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ILiAD Biotechnologies's 7 recorded funding rounds.

Premier Alternatives

ILiAD Biotechnologies

Drug Discovery · Weston, FL · Founded 2012 · Privately Held (backing)

Developer of a medical vaccine designed to prevent and offer treatment for human disease caused by Bordetella pertussis. ILiAD Biotechnologies is based in Weston, FL and was founded in 2012. It has raised $215 million across 7 recorded rounds; the latest was an $115 million Series B in Feb 2026.

Last price · $/share

—

Implied valuation

—

Total raised

$214.6M

Last round

Later Stage VC (Series B)

Feb 2026

Cap table — not yet on record

ILiAD Biotechnologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of ILiAD Biotechnologies with a free account

·The complete investor list: 11 names
·Watch ILiAD Biotechnologies: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about ILiAD Biotechnologies

Where does ILiAD Biotechnologies's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across ILiAD Biotechnologies's 7 recorded funding rounds.